Willingness to Co-receive COVID-19 and Influenza Vaccines among Outpatients

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Krissy Moehling Geffel, Mary Patricia Nowalk, Theresa M. Sax, Louise Taylor, Karen Clarke, Michael Susick, G.K. Balasubramani, Richard K. Zimmerman
{"title":"Willingness to Co-receive COVID-19 and Influenza Vaccines among Outpatients","authors":"Krissy Moehling Geffel, Mary Patricia Nowalk, Theresa M. Sax, Louise Taylor, Karen Clarke, Michael Susick, G.K. Balasubramani, Richard K. Zimmerman","doi":"10.5993/ajhb.47.4.8","DOIUrl":null,"url":null,"abstract":"Objectives: This study was designed to examine future willingness to co-receive COVID-19 and influenza vaccines and factors associated with that willingness among outpatients with acute respiratory illness (ARI). Methods: Outpatients ≥15 years with respiratory symptoms for ≤10 days were surveyed about vaccination behaviors and intentions. We used multinomial logistic regression to assess associations between demographic, behavioral and health-related variables and willingness to co-receive future COVID-19 and influenza vaccines. Results: Among 856 patients, 41% had received ≥1 COVID-19 vaccines plus booster and 42% had received seasonal influenza vaccine; 47% reported willingness to co-receive COVID-19 and influenza vaccines with 25% unsure and 28% unwilling. Higher educational attainment (OR=1.80, p=.009), receipt of ≥1 COVID-19 vaccines (OR=4.29, p<.001), greater 5-year influenza vaccine uptake (annually OR=8.54, p<.001; sometimes OR=5.38, p<.001) and lower likelihood of testing COVID-19 positive (OR=0.68, p=.033) were significantly associated with willingness to co-receive compared to those decidedly opposed. Conclusions: Prior vaccination behavior predicted willingness to co-receive future COVID-19 and influenza vaccines. Efforts to encourage co-receipt are more likely to succeed among routine vaccine recipients. Vaccination promotion efforts for those hesitant or unwilling to co-receive these vaccines may need to focus on improving uptake of each vaccine individually.","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5993/ajhb.47.4.8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study was designed to examine future willingness to co-receive COVID-19 and influenza vaccines and factors associated with that willingness among outpatients with acute respiratory illness (ARI). Methods: Outpatients ≥15 years with respiratory symptoms for ≤10 days were surveyed about vaccination behaviors and intentions. We used multinomial logistic regression to assess associations between demographic, behavioral and health-related variables and willingness to co-receive future COVID-19 and influenza vaccines. Results: Among 856 patients, 41% had received ≥1 COVID-19 vaccines plus booster and 42% had received seasonal influenza vaccine; 47% reported willingness to co-receive COVID-19 and influenza vaccines with 25% unsure and 28% unwilling. Higher educational attainment (OR=1.80, p=.009), receipt of ≥1 COVID-19 vaccines (OR=4.29, p<.001), greater 5-year influenza vaccine uptake (annually OR=8.54, p<.001; sometimes OR=5.38, p<.001) and lower likelihood of testing COVID-19 positive (OR=0.68, p=.033) were significantly associated with willingness to co-receive compared to those decidedly opposed. Conclusions: Prior vaccination behavior predicted willingness to co-receive future COVID-19 and influenza vaccines. Efforts to encourage co-receipt are more likely to succeed among routine vaccine recipients. Vaccination promotion efforts for those hesitant or unwilling to co-receive these vaccines may need to focus on improving uptake of each vaccine individually.
门诊患者联合接种COVID-19和流感疫苗的意愿
目的:本研究旨在调查急性呼吸道疾病(ARI)门诊患者未来联合接种COVID-19和流感疫苗的意愿以及与此意愿相关的因素。方法:对年龄≥15岁且呼吸道症状持续≤10天的门诊患者进行疫苗接种行为和意向调查。我们使用多项逻辑回归来评估人口统计学、行为和健康相关变量与共同接受未来COVID-19和流感疫苗的意愿之间的关联。结果:856例患者中,41%接种了≥1种COVID-19疫苗加强化疫苗,42%接种了季节性流感疫苗;47%的人表示愿意同时接种COVID-19和流感疫苗,25%的人不确定,28%的人不愿意。较高的受教育程度(OR=1.80, p= 0.009)、接种≥1支COVID-19疫苗(OR=4.29, p= 0.001)、较高的5年流感疫苗接种率(OR= 8.54, p= 0.001;有时OR=5.38, p= 0.001)和较低的COVID-19检测阳性的可能性(OR=0.68, p= 0.033)与坚决反对的患者相比,与共同接受意愿显著相关。结论:既往疫苗接种行为可预测未来联合接种COVID-19和流感疫苗的意愿。鼓励共同接种的努力更有可能在常规疫苗接受者中取得成功。对于那些犹豫不决或不愿共同接种这些疫苗的人,疫苗接种促进工作可能需要侧重于提高每种疫苗的吸收率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信